financetom
Business
financetom
/
Business
/
Ecolab Q2 Adjusted Earnings, Revenue Increase; Adjusts 2024 EPS Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ecolab Q2 Adjusted Earnings, Revenue Increase; Adjusts 2024 EPS Outlook
Jul 30, 2024 6:21 AM

08:46 AM EDT, 07/30/2024 (MT Newswires) -- Ecolab ( ECL ) reported Q2 adjusted earnings Tuesday of $1.68 per diluted share, up from $1.24 a year earlier.

Analysts polled by Capital IQ expected $1.67.

Revenue for the quarter ended June 30 was $3.99 billion compared with $3.85 billion a year earlier.

Analysts surveyed by Capital IQ expected $4.03 billion.

For Q3, the company expects adjusted diluted EPS in the range of $1.75 to $1.85. Analysts surveyed by Capital IQ expect $1.79 per share.

The company adjusted its 2024 non-GAAP diluted EPS guidance to $6.50 to $6.70 from the prior $6.40 to $6.70. Analysts surveyed by Capital IQ expect $6.58.

Ecolab ( ECL ) shares were down by more than 4% in recent premarket trading.

Price: 242.88, Change: -5.04, Percent Change: -2.03

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Irhythm Technologies Insider Sold Shares Worth $360,983, According to a Recent SEC Filing
Irhythm Technologies Insider Sold Shares Worth $360,983, According to a Recent SEC Filing
Mar 5, 2024
04:56 PM EST, 03/05/2024 (MT Newswires) -- Mark J. Day, Chief Technology Officer, on March 04, 2024, sold 3,248 shares in Irhythm Technologies ( IRTC ) for $360,983. Following the Form 4 filing with the SEC, Day has control over a total of 61,164 shares of the company, with 61,164 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1388658/000138865824000061/xslF345X03/wk-form4_1709675551.xml Price: 108.25, Change: +0.82,...
Avidity Biosciences Insider Sold Shares Worth $1,691,306, According to a Recent SEC Filing
Avidity Biosciences Insider Sold Shares Worth $1,691,306, According to a Recent SEC Filing
Mar 5, 2024
04:56 PM EST, 03/05/2024 (MT Newswires) -- Sarah Boyce, Director, President and CEO, on March 01, 2024, sold 84,000 shares in Avidity Biosciences ( RNA ) for $1,691,306. Following the Form 4 filing with the SEC, Boyce has control over a total of 112,117 shares of the company, with 112,117 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1599901/000159990124000038/xslF345X03/wk-form4_1709675574.xml Price: 19.52, Change: +0.38,...
Orthofix Medical Q4 Loss Widens, Sales Rise; 2024 Sales Outlook Set
Orthofix Medical Q4 Loss Widens, Sales Rise; 2024 Sales Outlook Set
Mar 5, 2024
04:57 PM EST, 03/05/2024 (MT Newswires) -- Orthofix Medical ( OFIX ) reported a Q4 loss late Tuesday of $0.59 per diluted share, wider than a loss of $0.35 a year earlier. Four analysts surveyed by Capital IQ expected a loss of $0.49. Net sales for the quarter ended Dec. 31 were $200.4 million, up from $122.2 million a year...
Skechers Usa Insider Sold Shares Worth $1,905,968, According to a Recent SEC Filing
Skechers Usa Insider Sold Shares Worth $1,905,968, According to a Recent SEC Filing
Mar 5, 2024
04:57 PM EST, 03/05/2024 (MT Newswires) -- Robert Greenberg, 10% Owner, Director, Chief Executive Officer, on March 01, 2024, sold 31,202 shares in Skechers Usa ( SKX ) for $1,905,968. Following the Form 4 filing with the SEC, Greenberg has control over a total of 136,617 shares of the company, with 132,783 shares held directly and 3,834 controlled indirectly. SEC...
Copyright 2023-2026 - www.financetom.com All Rights Reserved